APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-AIDs Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anti-AIDs Drug Market Analysis and Forecast 2026-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchAnti-AIDs Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-AIDs Drug Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Anti-AIDs Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-AIDs Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-AIDs Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Anti-AIDs Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Anti-AIDs Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anti-AIDs Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anti-AIDs Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anti-AIDs Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Anti-AIDs Drug include GSK, MSD, Gilead Sciences, Frontier Biotechnologies and Cipla, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Anti-AIDs Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-AIDs Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-AIDs Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-AIDs Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-AIDs Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anti-AIDs Drug sales, projected growth trends, production technology, application and end-user industry.

Anti-AIDs Drug Segment by Company

GSK

MSD

Gilead Sciences

Frontier Biotechnologies

Cipla

Anti-AIDs Drug Segment by Type

Prescription Drugs

Non-prescription Drugs

Anti-AIDs Drug Segment by Application

Pharmacy

Hospital

Anti-AIDs Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-AIDs Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-AIDs Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-AIDs Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Anti-AIDs Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Anti-AIDs Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-AIDs Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-AIDs Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prescription Drugs Major Manufacturers Table 3. Non-prescription Drugs Major Manufacturers Table 4. Global Anti-AIDs Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmacy Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Anti-AIDs Drug Industry Trends Table 8. Anti-AIDs Drug Industry Drivers Table 9. Anti-AIDs Drug Industry Opportunities and Challenges Table 10. Anti-AIDs Drug Industry Restraints Table 11. Global Anti-AIDs Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Anti-AIDs Drug Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Anti-AIDs Drug Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Anti-AIDs Drug Revenue Market Share by Region (2021-2026) Table 15. Global Anti-AIDs Drug Revenue Market Share by Region (2027-2032) Table 16. Global Anti-AIDs Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Anti-AIDs Drug Sales by Region (2021-2026) & (k units) Table 18. Global Anti-AIDs Drug Sales by Region (2027-2032) & (k units) Table 19. Global Anti-AIDs Drug Sales Market Share by Region (2021-2026) Table 20. Global Anti-AIDs Drug Sales Market Share by Region (2027-2032) Table 21. Global Anti-AIDs Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Anti-AIDs Drug Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Anti-AIDs Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Anti-AIDs Drug Sales Market Share by Manufacturers (2021-2026) Table 25. Global Anti-AIDs Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Anti-AIDs Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Anti-AIDs Drug Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Anti-AIDs Drug Manufacturers, Product Type & Application Table 29. Global Anti-AIDs Drug Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Anti-AIDs Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Anti-AIDs Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Anti-AIDs Drug Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Anti-AIDs Drug Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Anti-AIDs Drug Revenue Market Share by Type (2021-2026) Table 36. Global Anti-AIDs Drug Revenue Market Share by Type (2027-2032) Table 37. Global Anti-AIDs Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Anti-AIDs Drug Sales by Type (2021-2026) & (k units) Table 39. Global Anti-AIDs Drug Sales by Type (2027-2032) & (k units) Table 40. Global Anti-AIDs Drug Sales Market Share by Type (2021-2026) Table 41. Global Anti-AIDs Drug Sales Market Share by Type (2027-2032) Table 42. Global Anti-AIDs Drug Price by Type (2021-2026) & (US$/unit) Table 43. Global Anti-AIDs Drug Price by Type (2027-2032) & (US$/unit) Table 44. Global Anti-AIDs Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Anti-AIDs Drug Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Anti-AIDs Drug Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Anti-AIDs Drug Revenue Market Share by Application (2021-2026) Table 48. Global Anti-AIDs Drug Revenue Market Share by Application (2027-2032) Table 49. Global Anti-AIDs Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Anti-AIDs Drug Sales by Application (2021-2026) & (k units) Table 51. Global Anti-AIDs Drug Sales by Application (2027-2032) & (k units) Table 52. Global Anti-AIDs Drug Sales Market Share by Application (2021-2026) Table 53. Global Anti-AIDs Drug Sales Market Share by Application (2027-2032) Table 54. Global Anti-AIDs Drug Price by Application (2021-2026) & (US$/unit) Table 55. Global Anti-AIDs Drug Price by Application (2027-2032) & (US$/unit) Table 56. GSK Company Information Table 57. GSK Business Overview Table 58. GSK Anti-AIDs Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. GSK Anti-AIDs Drug Product Portfolio Table 60. GSK Recent Development Table 61. MSD Company Information Table 62. MSD Business Overview Table 63. MSD Anti-AIDs Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. MSD Anti-AIDs Drug Product Portfolio Table 65. MSD Recent Development Table 66. Gilead Sciences Company Information Table 67. Gilead Sciences Business Overview Table 68. Gilead Sciences Anti-AIDs Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Gilead Sciences Anti-AIDs Drug Product Portfolio Table 70. Gilead Sciences Recent Development Table 71. Frontier Biotechnologies Company Information Table 72. Frontier Biotechnologies Business Overview Table 73. Frontier Biotechnologies Anti-AIDs Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Frontier Biotechnologies Anti-AIDs Drug Product Portfolio Table 75. Frontier Biotechnologies Recent Development Table 76. Cipla Company Information Table 77. Cipla Business Overview Table 78. Cipla Anti-AIDs Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Cipla Anti-AIDs Drug Product Portfolio Table 80. Cipla Recent Development Table 81. North America Anti-AIDs Drug Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Anti-AIDs Drug Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Anti-AIDs Drug Sales by Type (2021-2026) & (k units) Table 84. North America Anti-AIDs Drug Sales by Type (2027-2032) & (k units) Table 85. North America Anti-AIDs Drug Sales Price by Type (2021-2026) & (US$/unit) Table 86. North America Anti-AIDs Drug Sales Price by Type (2027-2032) & (US$/unit) Table 87. North America Anti-AIDs Drug Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Anti-AIDs Drug Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Anti-AIDs Drug Sales by Application (2021-2026) & (k units) Table 90. North America Anti-AIDs Drug Sales by Application (2027-2032) & (k units) Table 91. North America Anti-AIDs Drug Sales Price by Application (2021-2026) & (US$/unit) Table 92. North America Anti-AIDs Drug Sales Price by Application (2027-2032) & (US$/unit) Table 93. North America Anti-AIDs Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Anti-AIDs Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America Anti-AIDs Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America Anti-AIDs Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 97. North America Anti-AIDs Drug Sales by Country (2021-2026) & (k units) Table 98. North America Anti-AIDs Drug Sales by Country (2027-2032) & (k units) Table 99. North America Anti-AIDs Drug Sales Price by Country (2021-2026) & (US$/unit) Table 100. North America Anti-AIDs Drug Sales Price by Country (2027-2032) & (US$/unit) Table 101. United States Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 102. Canada Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 103. Mexico Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 104. Europe Anti-AIDs Drug Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Anti-AIDs Drug Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Anti-AIDs Drug Sales by Type (2021-2026) & (k units) Table 107. Europe Anti-AIDs Drug Sales by Type (2027-2032) & (k units) Table 108. Europe Anti-AIDs Drug Sales Price by Type (2021-2026) & (US$/unit) Table 109. Europe Anti-AIDs Drug Sales Price by Type (2027-2032) & (US$/unit) Table 110. Europe Anti-AIDs Drug Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Anti-AIDs Drug Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Anti-AIDs Drug Sales by Application (2021-2026) & (k units) Table 113. Europe Anti-AIDs Drug Sales by Application (2027-2032) & (k units) Table 114. Europe Anti-AIDs Drug Sales Price by Application (2021-2026) & (US$/unit) Table 115. Europe Anti-AIDs Drug Sales Price by Application (2027-2032) & (US$/unit) Table 116. Europe Anti-AIDs Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Anti-AIDs Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Anti-AIDs Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Anti-AIDs Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 120. Europe Anti-AIDs Drug Sales by Country (2021-2026) & (k units) Table 121. Europe Anti-AIDs Drug Sales by Country (2027-2032) & (k units) Table 122. Europe Anti-AIDs Drug Sales Price by Country (2021-2026) & (US$/unit) Table 123. Europe Anti-AIDs Drug Sales Price by Country (2027-2032) & (US$/unit) Table 124. Germany Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 125. France Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 126. U.K. Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 127. Italy Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 128. Russia Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 129. Spain Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 131. Switzerland Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 132. Sweden Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 133. Poland Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 134. China Anti-AIDs Drug Revenue by Type (2021-2026) & (US$ Million) Table 135. China Anti-AIDs Drug Revenue by Type (2027-2032) & (US$ Million) Table 136. China Anti-AIDs Drug Sales by Type (2021-2026) & (k units) Table 137. China Anti-AIDs Drug Sales by Type (2027-2032) & (k units) Table 138. China Anti-AIDs Drug Sales Price by Type (2021-2026) & (US$/unit) Table 139. China Anti-AIDs Drug Sales Price by Type (2027-2032) & (US$/unit) Table 140. China Anti-AIDs Drug Revenue by Application (2021-2026) & (US$ Million) Table 141. China Anti-AIDs Drug Revenue by Application (2027-2032) & (US$ Million) Table 142. China Anti-AIDs Drug Sales by Application (2021-2026) & (k units) Table 143. China Anti-AIDs Drug Sales by Application (2027-2032) & (k units) Table 144. China Anti-AIDs Drug Sales Price by Application (2021-2026) & (US$/unit) Table 145. China Anti-AIDs Drug Sales Price by Application (2027-2032) & (US$/unit) Table 146. Asia Anti-AIDs Drug Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Anti-AIDs Drug Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Anti-AIDs Drug Sales by Type (2021-2026) & (k units) Table 149. Asia Anti-AIDs Drug Sales by Type (2027-2032) & (k units) Table 150. Asia Anti-AIDs Drug Sales Price by Type (2021-2026) & (US$/unit) Table 151. Asia Anti-AIDs Drug Sales Price by Type (2027-2032) & (US$/unit) Table 152. Asia Anti-AIDs Drug Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Anti-AIDs Drug Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Anti-AIDs Drug Sales by Application (2021-2026) & (k units) Table 155. Asia Anti-AIDs Drug Sales by Application (2027-2032) & (k units) Table 156. Asia Anti-AIDs Drug Sales Price by Application (2021-2026) & (US$/unit) Table 157. Asia Anti-AIDs Drug Sales Price by Application (2027-2032) & (US$/unit) Table 158. Asia Anti-AIDs Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Anti-AIDs Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Anti-AIDs Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Anti-AIDs Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 162. Asia Anti-AIDs Drug Sales by Country (2021-2026) & (k units) Table 163. Asia Anti-AIDs Drug Sales by Country (2027-2032) & (k units) Table 164. Asia Anti-AIDs Drug Sales Price by Country (2021-2026) & (US$/unit) Table 165. Asia Anti-AIDs Drug Sales Price by Country (2027-2032) & (US$/unit) Table 166. Japan Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 167. South Korea Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 168. India Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 169. Australia Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 170. Taiwan Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Anti-AIDs Drug Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Anti-AIDs Drug Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Anti-AIDs Drug Sales by Type (2021-2026) & (k units) Table 175. SAMEA Anti-AIDs Drug Sales by Type (2027-2032) & (k units) Table 176. SAMEA Anti-AIDs Drug Sales Price by Type (2021-2026) & (US$/unit) Table 177. SAMEA Anti-AIDs Drug Sales Price by Type (2027-2032) & (US$/unit) Table 178. SAMEA Anti-AIDs Drug Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Anti-AIDs Drug Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Anti-AIDs Drug Sales by Application (2021-2026) & (k units) Table 181. SAMEA Anti-AIDs Drug Sales by Application (2027-2032) & (k units) Table 182. SAMEA Anti-AIDs Drug Sales Price by Application (2021-2026) & (US$/unit) Table 183. SAMEA Anti-AIDs Drug Sales Price by Application (2027-2032) & (US$/unit) Table 184. SAMEA Anti-AIDs Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Anti-AIDs Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Anti-AIDs Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Anti-AIDs Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 188. SAMEA Anti-AIDs Drug Sales by Country (2021-2026) & (k units) Table 189. SAMEA Anti-AIDs Drug Sales by Country (2027-2032) & (k units) Table 190. SAMEA Anti-AIDs Drug Sales Price by Country (2021-2026) & (US$/unit) Table 191. SAMEA Anti-AIDs Drug Sales Price by Country (2027-2032) & (US$/unit) Table 192. Brazil Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 193. Argentina Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 194. Chile Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 195. Colombia Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 196. Peru Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 198. Israel Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 199. UAE Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 200. Turkey Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 201. Iran Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 202. Egypt Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Anti-AIDs Drug Distributors List Table 206. Anti-AIDs Drug Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Anti-AIDs Drug Image Figure 2. Global Anti-AIDs Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-AIDs Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prescription Drugs Image Figure 5. Non-prescription Drugs Image Figure 6. Global Anti-AIDs Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Anti-AIDs Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmacy Image Figure 9. Hospital Image Figure 10. Global Anti-AIDs Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Anti-AIDs Drug Revenue (2021-2032) & (US$ Million) Figure 12. Global Anti-AIDs Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Anti-AIDs Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Anti-AIDs Drug Revenue Market Share by Region (2021-2032) Figure 15. Global Anti-AIDs Drug Sales (2021-2032) & (k units) Figure 16. Global Anti-AIDs Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Anti-AIDs Drug Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Anti-AIDs Drug Sales YoY (2021-2032) & (k units) Figure 19. Europe Anti-AIDs Drug Sales YoY (2021-2032) & (k units) Figure 20. China Anti-AIDs Drug Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Anti-AIDs Drug Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Anti-AIDs Drug Sales YoY (2021-2032) & (k units) Figure 23. Global Anti-AIDs Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Anti-AIDs Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Anti-AIDs Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Anti-AIDs Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Anti-AIDs Drug Revenue Market Share by Type (2021-2032) Figure 29. Global Anti-AIDs Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Anti-AIDs Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Anti-AIDs Drug Sales Market Share by Type (2021-2032) Figure 32. Global Anti-AIDs Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Anti-AIDs Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Anti-AIDs Drug Revenue Market Share by Application (2021-2032) Figure 35. Global Anti-AIDs Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Anti-AIDs Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Anti-AIDs Drug Sales Market Share by Application (2021-2032) Figure 38. North America Anti-AIDs Drug Revenue Share by Type (2021-2032) Figure 39. North America Anti-AIDs Drug Sales Share by Type (2021-2032) Figure 40. North America Anti-AIDs Drug Revenue Share by Application (2021-2032) Figure 41. North America Anti-AIDs Drug Sales Share by Application (2021-2032) Figure 42. North America Anti-AIDs Drug Revenue Share by Country (2021-2032) Figure 43. North America Anti-AIDs Drug Sales Share by Country (2021-2032) Figure 44. Europe Anti-AIDs Drug Revenue Share by Type (2021-2032) Figure 45. Europe Anti-AIDs Drug Sales Share by Type (2021-2032) Figure 46. Europe Anti-AIDs Drug Revenue Share by Application (2021-2032) Figure 47. Europe Anti-AIDs Drug Sales Share by Application (2021-2032) Figure 48. Europe Anti-AIDs Drug Revenue Share by Country (2021-2032) Figure 49. Europe Anti-AIDs Drug Sales Share by Country (2021-2032) Figure 50. China Anti-AIDs Drug Revenue Share by Type (2021-2032) Figure 51. China Anti-AIDs Drug Sales Share by Type (2021-2032) Figure 52. China Anti-AIDs Drug Revenue Share by Application (2021-2032) Figure 53. China Anti-AIDs Drug Sales Share by Application (2021-2032) Figure 54. Asia Anti-AIDs Drug Revenue Share by Type (2021-2032) Figure 55. Asia Anti-AIDs Drug Sales Share by Type (2021-2032) Figure 56. Asia Anti-AIDs Drug Revenue Share by Application (2021-2032) Figure 57. Asia Anti-AIDs Drug Sales Share by Application (2021-2032) Figure 58. Asia Anti-AIDs Drug Revenue Share by Country (2021-2032) Figure 59. Asia Anti-AIDs Drug Sales Share by Country (2021-2032) Figure 60. SAMEA Anti-AIDs Drug Revenue Share by Type (2021-2032) Figure 61. SAMEA Anti-AIDs Drug Sales Share by Type (2021-2032) Figure 62. SAMEA Anti-AIDs Drug Revenue Share by Application (2021-2032) Figure 63. SAMEA Anti-AIDs Drug Sales Share by Application (2021-2032) Figure 64. SAMEA Anti-AIDs Drug Revenue Share by Country (2021-2032) Figure 65. SAMEA Anti-AIDs Drug Sales Share by Country (2021-2032) Figure 66. Anti-AIDs Drug Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Anti-AIDs Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Drugs
  • Non-prescription Drugs
Applications
  • Pharmacy
  • Hospital
Companies covered
  • GSK
  • MSD
  • Gilead Sciences
  • Frontier Biotechnologies
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-AIDs Drug Market by Type
  3. 1.2.1 Global Anti-AIDs Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prescription Drugs
  5. 1.2.3 Non-prescription Drugs
  6. 1.3 Anti-AIDs Drug Market by Application
  7. 1.3.1 Global Anti-AIDs Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmacy
  9. 1.3.3 Hospital
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Anti-AIDs Drug Market Dynamics
  1. 2.1 Anti-AIDs Drug Industry Trends
  2. 2.2 Anti-AIDs Drug Industry Drivers
  3. 2.3 Anti-AIDs Drug Industry Opportunities and Challenges
  4. 2.4 Anti-AIDs Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Anti-AIDs Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Anti-AIDs Drug Revenue by Region
  3. 3.2.1 Global Anti-AIDs Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-AIDs Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Anti-AIDs Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Anti-AIDs Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Anti-AIDs Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Anti-AIDs Drug Sales by Region
  9. 3.4.1 Global Anti-AIDs Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Anti-AIDs Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Anti-AIDs Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Anti-AIDs Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Anti-AIDs Drug Revenue by Manufacturers
  2. 4.1.1 Global Anti-AIDs Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Anti-AIDs Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Anti-AIDs Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-AIDs Drug Sales by Manufacturers
  6. 4.2.1 Global Anti-AIDs Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Anti-AIDs Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Anti-AIDs Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Anti-AIDs Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Anti-AIDs Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Anti-AIDs Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Anti-AIDs Drug Manufacturers, Product Type & Application
  13. 4.7 Global Anti-AIDs Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Anti-AIDs Drug Market CR5 and HHI
  16. 4.8.2 2025 Anti-AIDs Drug Tier 1, Tier 2, and Tier 3
5 Anti-AIDs Drug Market by Type
  1. 5.1 Global Anti-AIDs Drug Revenue by Type
  2. 5.1.1 Global Anti-AIDs Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Anti-AIDs Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Anti-AIDs Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Anti-AIDs Drug Sales by Type
  6. 5.2.1 Global Anti-AIDs Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-AIDs Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Anti-AIDs Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Anti-AIDs Drug Price by Type
6 Anti-AIDs Drug Market by Application
  1. 6.1 Global Anti-AIDs Drug Revenue by Application
  2. 6.1.1 Global Anti-AIDs Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Anti-AIDs Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Anti-AIDs Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Anti-AIDs Drug Sales by Application
  6. 6.2.1 Global Anti-AIDs Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Anti-AIDs Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Anti-AIDs Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Anti-AIDs Drug Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Anti-AIDs Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Anti-AIDs Drug Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 MSD
  8. 7.2.1 MSD Company Information
  9. 7.2.2 MSD Business Overview
  10. 7.2.3 MSD Anti-AIDs Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 MSD Anti-AIDs Drug Product Portfolio
  12. 7.2.5 MSD Recent Developments
  13. 7.3 Gilead Sciences
  14. 7.3.1 Gilead Sciences Company Information
  15. 7.3.2 Gilead Sciences Business Overview
  16. 7.3.3 Gilead Sciences Anti-AIDs Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Gilead Sciences Anti-AIDs Drug Product Portfolio
  18. 7.3.5 Gilead Sciences Recent Developments
  19. 7.4 Frontier Biotechnologies
  20. 7.4.1 Frontier Biotechnologies Company Information
  21. 7.4.2 Frontier Biotechnologies Business Overview
  22. 7.4.3 Frontier Biotechnologies Anti-AIDs Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Frontier Biotechnologies Anti-AIDs Drug Product Portfolio
  24. 7.4.5 Frontier Biotechnologies Recent Developments
  25. 7.5 Cipla
  26. 7.5.1 Cipla Company Information
  27. 7.5.2 Cipla Business Overview
  28. 7.5.3 Cipla Anti-AIDs Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cipla Anti-AIDs Drug Product Portfolio
  30. 7.5.5 Cipla Recent Developments
8 North America
  1. 8.1 North America Anti-AIDs Drug Market Size by Type
  2. 8.1.1 North America Anti-AIDs Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Anti-AIDs Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Anti-AIDs Drug Price by Type (2021-2032)
  5. 8.2 North America Anti-AIDs Drug Market Size by Application
  6. 8.2.1 North America Anti-AIDs Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Anti-AIDs Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Anti-AIDs Drug Price by Application (2021-2032)
  9. 8.3 North America Anti-AIDs Drug Market Size by Country
  10. 8.3.1 North America Anti-AIDs Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Anti-AIDs Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Anti-AIDs Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Anti-AIDs Drug Market Size by Type
  2. 9.1.1 Europe Anti-AIDs Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Anti-AIDs Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Anti-AIDs Drug Price by Type (2021-2032)
  5. 9.2 Europe Anti-AIDs Drug Market Size by Application
  6. 9.2.1 Europe Anti-AIDs Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Anti-AIDs Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Anti-AIDs Drug Price by Application (2021-2032)
  9. 9.3 Europe Anti-AIDs Drug Market Size by Country
  10. 9.3.1 Europe Anti-AIDs Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Anti-AIDs Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Anti-AIDs Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Anti-AIDs Drug Market Size by Type
  2. 10.1.1 China Anti-AIDs Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Anti-AIDs Drug Sales by Type (2021-2032)
  4. 10.1.3 China Anti-AIDs Drug Price by Type (2021-2032)
  5. 10.2 China Anti-AIDs Drug Market Size by Application
  6. 10.2.1 China Anti-AIDs Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Anti-AIDs Drug Sales by Application (2021-2032)
  8. 10.2.3 China Anti-AIDs Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-AIDs Drug Market Size by Type
  2. 11.1.1 Asia Anti-AIDs Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Anti-AIDs Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Anti-AIDs Drug Price by Type (2021-2032)
  5. 11.2 Asia Anti-AIDs Drug Market Size by Application
  6. 11.2.1 Asia Anti-AIDs Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Anti-AIDs Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Anti-AIDs Drug Price by Application (2021-2032)
  9. 11.3 Asia Anti-AIDs Drug Market Size by Country
  10. 11.3.1 Asia Anti-AIDs Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Anti-AIDs Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Anti-AIDs Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-AIDs Drug Market Size by Type
  2. 12.1.1 SAMEA Anti-AIDs Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Anti-AIDs Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Anti-AIDs Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Anti-AIDs Drug Market Size by Application
  6. 12.2.1 SAMEA Anti-AIDs Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Anti-AIDs Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Anti-AIDs Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Anti-AIDs Drug Market Size by Country
  10. 12.3.1 SAMEA Anti-AIDs Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Anti-AIDs Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Anti-AIDs Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Anti-AIDs Drug Value Chain Analysis
  2. 13.1.1 Anti-AIDs Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Anti-AIDs Drug Production Mode & Process
  6. 13.2 Anti-AIDs Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Anti-AIDs Drug Distributors
  9. 13.2.3 Anti-AIDs Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst